These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 37044278)
1. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention. Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278 [TBL] [Abstract][Full Text] [Related]
2. All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for Failure. Schlenker MB; Armstrong JJ; De Francesco T; Ahmed IIK Am J Ophthalmol; 2023 Nov; 255():125-140. PubMed ID: 37352909 [TBL] [Abstract][Full Text] [Related]
3. Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C. Schlenker MB; Durr GM; Michaelov E; Ahmed IIK Am J Ophthalmol; 2020 Jul; 215():141-153. PubMed ID: 32173344 [TBL] [Abstract][Full Text] [Related]
4. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma. Durr GM; Schlenker MB; Samet S; Ahmed IIK Br J Ophthalmol; 2022 Jan; 106(1):71-79. PubMed ID: 33097520 [TBL] [Abstract][Full Text] [Related]
5. Mitomycin C 0.2 mg/ml versus Mitomycin C 0.4 mg/ml during the Implantation of an Ab Externo Polystyrene-isobutylene-styrene Microshunt: A Mega-analysis. De Francesco T; Armstrong JJ; Hussein IM; Costa VP; Ahmed IIK Ophthalmol Glaucoma; 2024; 7(5):454-465. PubMed ID: 38851392 [TBL] [Abstract][Full Text] [Related]
7. Intermediate Outcomes of the Novel 63-μm Gelatin Microstent versus the Conventional 45-μm Gelatin Microstent. Hussein IM; De Francesco T; Ahmed IIK Ophthalmol Glaucoma; 2023; 6(6):580-591. PubMed ID: 37169174 [TBL] [Abstract][Full Text] [Related]
8. Comparing Outcomes of Trabeculectomy with Mitomycin C to 45 μm Gelatin Stent Placed Ab Externo with Open Conjunctiva. Sabogal E; Ingram Z; Odishelidze N; El Helwe H; Falah HK; Trzcinski J; Hall N; Solá-Del Valle D Ophthalmol Glaucoma; 2024; 7(3):232-241. PubMed ID: 38056708 [TBL] [Abstract][Full Text] [Related]
9. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Beckers HJM; Aptel F; Webers CAB; Bluwol E; Martínez-de-la-Casa JM; García-Feijoó J; Lachkar Y; Méndez-Hernández CD; Riss I; Shao H; Pinchuk L; Angeles R; Sadruddin O; Shaarawy TM Ophthalmol Glaucoma; 2022; 5(2):195-209. PubMed ID: 34329772 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study. Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904 [TBL] [Abstract][Full Text] [Related]
12. A 2-Year, Single-Center Study to Assess the Safety and Effectiveness of the MicroShunt in Primary Open-Angle Glaucoma. Riss I Ophthalmic Res; 2023; 66(1):206-217. PubMed ID: 36137526 [TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom. Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750 [TBL] [Abstract][Full Text] [Related]
14. Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy. Schlenker MB; Gulamhusein H; Conrad-Hengerer I; Somers A; Lenzhofer M; Stalmans I; Reitsamer H; Hengerer FH; Ahmed IIK Ophthalmology; 2017 Nov; 124(11):1579-1588. PubMed ID: 28601250 [TBL] [Abstract][Full Text] [Related]
15. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135 [TBL] [Abstract][Full Text] [Related]
16. Ab interno trabeculectomy versus trabeculectomy for open-angle glaucoma. Jea SY; Francis BA; Vakili G; Filippopoulos T; Rhee DJ Ophthalmology; 2012 Jan; 119(1):36-42. PubMed ID: 21982416 [TBL] [Abstract][Full Text] [Related]
17. Ab externo implantation of the MicroShunt, a poly (styrene- Sadruddin O; Pinchuk L; Angeles R; Palmberg P Eye Vis (Lond); 2019; 6():36. PubMed ID: 31807606 [TBL] [Abstract][Full Text] [Related]
18. Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction. Ibarz Barberá M; Morales Fernández L; Tañá Rivero P; Gómez de Liaño R; Teus MA Acta Ophthalmol; 2022 Feb; 100(1):e192-e203. PubMed ID: 33838021 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life. Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044 [TBL] [Abstract][Full Text] [Related]
20. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation. Vastardis I; Fili S; Perdikakis G; Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M Eye Vis (Lond); 2021 Sep; 8(1):33. PubMed ID: 34479641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]